JP2013517784A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013517784A5 JP2013517784A5 JP2012550449A JP2012550449A JP2013517784A5 JP 2013517784 A5 JP2013517784 A5 JP 2013517784A5 JP 2012550449 A JP2012550449 A JP 2012550449A JP 2012550449 A JP2012550449 A JP 2012550449A JP 2013517784 A5 JP2013517784 A5 JP 2013517784A5
- Authority
- JP
- Japan
- Prior art keywords
- cect
- strain
- activity
- deposited
- lactobacillus plantarum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 15
- 240000006024 Lactobacillus plantarum Species 0.000 claims 14
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims 14
- 229940072205 lactobacillus plantarum Drugs 0.000 claims 14
- 230000000694 effects Effects 0.000 claims 10
- 241000191998 Pediococcus acidilactici Species 0.000 claims 7
- 206010000060 Abdominal distension Diseases 0.000 claims 6
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims 5
- 230000000813 microbial effect Effects 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000000968 intestinal effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000008520 organization Effects 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000020560 abdominal swelling Diseases 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 230000004957 immunoregulator effect Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 238000002703 mutagenesis Methods 0.000 claims 1
- 231100000350 mutagenesis Toxicity 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 239000000273 veterinary drug Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29911610P | 2010-01-28 | 2010-01-28 | |
| US61/299,116 | 2010-01-28 | ||
| EP10151998.1 | 2010-01-28 | ||
| EP10151998 | 2010-01-28 | ||
| PCT/EP2011/051170 WO2011092261A1 (en) | 2010-01-28 | 2011-01-27 | Probiotic composition for use in the treatment of bowel inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013517784A JP2013517784A (ja) | 2013-05-20 |
| JP2013517784A5 true JP2013517784A5 (enExample) | 2014-03-13 |
| JP5777640B2 JP5777640B2 (ja) | 2015-09-09 |
Family
ID=42243204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012550449A Active JP5777640B2 (ja) | 2010-01-28 | 2011-01-27 | 腸炎症の処置における使用のためのプロバイオティクス組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20130101566A1 (enExample) |
| EP (1) | EP2528610B1 (enExample) |
| JP (1) | JP5777640B2 (enExample) |
| KR (1) | KR101840239B1 (enExample) |
| CN (1) | CN102905712B (enExample) |
| AU (1) | AU2011209407B2 (enExample) |
| BR (1) | BR112012018813B1 (enExample) |
| CA (1) | CA2787544C (enExample) |
| CL (1) | CL2012002062A1 (enExample) |
| CO (1) | CO6511276A2 (enExample) |
| ES (1) | ES2437940T3 (enExample) |
| MX (1) | MX2012008817A (enExample) |
| MY (1) | MY162344A (enExample) |
| PH (1) | PH12012501540A1 (enExample) |
| PL (1) | PL2528610T3 (enExample) |
| RU (1) | RU2563525C2 (enExample) |
| UA (1) | UA109123C2 (enExample) |
| WO (1) | WO2011092261A1 (enExample) |
| ZA (1) | ZA201205683B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| CN113151045A (zh) * | 2011-06-10 | 2021-07-23 | 株式会社爱茉莉太平洋 | 分离自茶树叶的新型植物乳杆菌 |
| JP5995593B2 (ja) * | 2012-08-02 | 2016-09-21 | 丸善製薬株式会社 | 抗炎症剤 |
| WO2014096901A1 (en) * | 2012-12-18 | 2014-06-26 | Compagnie Gervais Danone | Strain of bifidobacterium animalis ssp. animalis |
| WO2014168474A1 (en) * | 2013-04-08 | 2014-10-16 | N.V. Nutricia | Fermented nutritional composition with thiol protease inhibitor |
| SI24570A (sl) | 2013-12-23 | 2015-06-30 | Medis D.O.O. | Novi sevi rodu Lactobacillus in njihova uporaba |
| JP6781887B2 (ja) * | 2014-02-28 | 2020-11-11 | 株式会社明治 | 機能性消化管障害予防及び／又は改善剤 |
| US10967013B2 (en) * | 2014-04-23 | 2021-04-06 | National Yang-Ming University | Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same |
| US10188684B2 (en) * | 2015-04-20 | 2019-01-29 | National Yang-Ming University | Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium |
| WO2016083450A2 (en) * | 2014-11-25 | 2016-06-02 | Stichting Top Institute Food And Nutrition | New probiotic and new biomarker |
| PL3223838T3 (pl) * | 2014-11-28 | 2025-05-26 | Anagenix Ip Limited | Kompozycje i sposoby przygotowywania i stosowania żółtego kiwi |
| US10195237B2 (en) * | 2015-03-16 | 2019-02-05 | Imagilin Technology Llc | Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics |
| US10946050B2 (en) | 2015-03-16 | 2021-03-16 | Imagilin Technology Llc | Compositions comprising probiotics and methods of use thereof |
| MA41010B1 (fr) * | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| US10857190B2 (en) | 2015-10-06 | 2020-12-08 | Albert Einstein College Of Medicine | Microbial hyperswarmers and uses thereof |
| CA3052134C (en) | 2017-01-31 | 2023-01-03 | University-Industry Cooperation Group Of Kyung Hee University | Novel lactic acid bacteria and use thereof |
| KR102464397B1 (ko) * | 2017-09-15 | 2022-11-08 | (주)아모레퍼시픽 | 락토바실러스 플란타룸을 포함하는 위장관 질환의 예방 및 개선용 조성물 |
| KR102265538B1 (ko) | 2018-02-02 | 2021-06-16 | 주식회사 고바이오랩 | 락토바실러스 플란타럼 kbl396 균주 및 그 용도 |
| WO2019178486A1 (en) | 2018-03-15 | 2019-09-19 | University Of Southern California | Fasting-mimicking diet (fmd) but not water-only fasting promotes reversal of inflammation and ibd pathology |
| KR102118343B1 (ko) * | 2018-07-13 | 2020-06-03 | 롯데푸드 주식회사 | 장 도달력이 우수하고 장내 염증 예방 효과를 가지는 우유와 발효유 |
| AR115757A1 (es) * | 2018-07-13 | 2021-02-24 | Cj Cheiljedang Corp | Composición que comprende la cepa cjlp475 de lactobacillus plantarum y la cepa cjlp17 de lactobacillus plantarum y el uso de la misma |
| KR102036275B1 (ko) * | 2018-10-02 | 2019-10-24 | 서울대학교 산학협력단 | 항-염증 활성이 우수한 페디오코커스 악시딜락티시 ldtm 5201 신균주(kctc 13563bp) |
| KR102038695B1 (ko) * | 2018-10-30 | 2019-10-30 | 주식회사 종근당바이오 | 프로바이오틱스를 유효성분으로 포함하는 알코올성 장손상 예방 또는 치료용 조성물 |
| US20220054561A1 (en) * | 2018-12-14 | 2022-02-24 | The University Of North Carolina At Chapel Hill | Lachnospiraceae mitigates against radiation-induced hematopoietic/gastrointestinal injury and death, and promotes cancer control by radiation |
| KR102094415B1 (ko) * | 2018-12-17 | 2020-03-30 | 강원대학교산학협력단 | 프로바이오틱 활성 및 항균활성을 갖는 페디오코커스 애시디락티시 균주 |
| KR102500854B1 (ko) * | 2019-12-17 | 2023-02-17 | 한국 한의학 연구원 | 페디오코쿠스 이노피나투스를 유효성분으로 포함하는 숙취해소용 조성물 |
| WO2022171304A1 (en) * | 2021-02-12 | 2022-08-18 | Ab-Biotics, S.A. | Probiotic composition for the treatment of covid-19 |
| AU2023233349A1 (en) | 2022-03-17 | 2024-10-10 | Kaneka Corporation | Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application |
| CN114921351B (zh) * | 2022-05-06 | 2023-06-13 | 大连工业大学 | 一株具有益生功能的毕赤酵母菌dpuy-f1及在缓解结肠炎症状中的应用 |
| CN116083277B (zh) * | 2022-09-17 | 2024-02-13 | 浙江大学 | 具有缓解溃疡性结肠炎功效的乳酸片球菌zjuids13及其应用 |
| KR20240102112A (ko) * | 2022-12-23 | 2024-07-03 | 주식회사 씨티씨바이오 | 대장염 예방 또는 치료활성 및 장내 유해균에 항균활성을 지닌 락토바실러스 및 그의 용도 |
| KR102803865B1 (ko) * | 2023-07-31 | 2025-05-09 | 전라남도 | 사료첨가제 및 이를 포함하는 사료 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE463796B (sv) | 1988-03-09 | 1991-01-28 | Carl Erik Albertsson | Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition |
| SE469875C (sv) | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
| SE9501056D0 (sv) | 1995-03-23 | 1995-03-23 | Probi Ab | Epithelial adherent lactobacilli |
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| FR2813790B1 (fr) * | 2000-09-11 | 2004-03-12 | Dolisos Lab | Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| WO2004110466A2 (en) * | 2003-06-13 | 2004-12-23 | N.V. Nutricia | Pediocin-producing pediococci |
| DE602004030922D1 (de) * | 2003-08-21 | 2011-02-17 | Otsuka Pharma Co Ltd | Milchsäurebakterien mit mucosa-immunpotenzierungseffekt |
| EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
| AT501919B1 (de) * | 2005-06-14 | 2008-09-15 | Erber Ag | Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung |
| EP1951273B1 (en) * | 2005-10-06 | 2014-02-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| ATE483366T1 (de) * | 2005-11-14 | 2010-10-15 | Unilever Nv | Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält |
| US20070298013A1 (en) | 2006-06-23 | 2007-12-27 | Altman Jay A | Animal Nutritional Supplement and Method |
| JP2008013534A (ja) * | 2006-07-07 | 2008-01-24 | Health Vision:Kk | ペット用プロバイオティクス製品 |
| EP2265135B1 (en) * | 2008-03-14 | 2017-12-20 | Nestec S.A. | Synbiotic mixture |
| WO2010114864A1 (en) * | 2009-04-01 | 2010-10-07 | Little Calumet Holdings, Llc | Probiotic oral dosage forms |
| US8298526B2 (en) * | 2010-06-02 | 2012-10-30 | Genmont Biotech Inc. | Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
| WO2015021530A1 (en) * | 2013-08-12 | 2015-02-19 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
-
2011
- 2011-01-27 WO PCT/EP2011/051170 patent/WO2011092261A1/en not_active Ceased
- 2011-01-27 RU RU2012136615/10A patent/RU2563525C2/ru active
- 2011-01-27 EP EP11702426.5A patent/EP2528610B1/en active Active
- 2011-01-27 KR KR1020127021713A patent/KR101840239B1/ko active Active
- 2011-01-27 PL PL11702426T patent/PL2528610T3/pl unknown
- 2011-01-27 UA UAA201210207A patent/UA109123C2/ru unknown
- 2011-01-27 ES ES11702426.5T patent/ES2437940T3/es active Active
- 2011-01-27 CN CN201180007399.0A patent/CN102905712B/zh active Active
- 2011-01-27 JP JP2012550449A patent/JP5777640B2/ja active Active
- 2011-01-27 PH PH1/2012/501540A patent/PH12012501540A1/en unknown
- 2011-01-27 CA CA2787544A patent/CA2787544C/en active Active
- 2011-01-27 BR BR112012018813-5A patent/BR112012018813B1/pt active IP Right Grant
- 2011-01-27 MX MX2012008817A patent/MX2012008817A/es active IP Right Grant
- 2011-01-27 AU AU2011209407A patent/AU2011209407B2/en active Active
- 2011-01-27 MY MYPI2012003332A patent/MY162344A/en unknown
- 2011-01-27 US US13/575,865 patent/US20130101566A1/en not_active Abandoned
-
2012
- 2012-07-25 CL CL2012002062A patent/CL2012002062A1/es unknown
- 2012-07-25 CO CO12125095A patent/CO6511276A2/es unknown
- 2012-07-27 ZA ZA2012/05683A patent/ZA201205683B/en unknown
-
2016
- 2016-04-21 US US15/134,558 patent/US10155015B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013517784A5 (enExample) | ||
| RU2012136615A (ru) | Пробиотическая композиция для применения в лечении воспаления кишечника | |
| Al-Tawaha et al. | Potential benefits of Lactobacillus plantarum as probiotic and its advantages in human health and industrial applications: A review | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| JP2019508486A5 (enExample) | ||
| Patel et al. | Probiotics in valorization of innate immunity across various animal models | |
| RU2012118639A (ru) | ШТАММЫ Lactobacillus plantarum В КАЧЕСТВЕ ГИПОХОЛЕСТЕРИНЕМИЧЕСКИХ АГЕНТОВ | |
| Ren et al. | Evaluation of immunomodulatory activity of two potential probiotic Lactobacillus strains by in vivo tests | |
| HRP20191440T1 (hr) | Sastavi koji sadrže bakterijske sojeve | |
| HRP20180152T1 (hr) | Sojevi bakterija koji su izolirani iz svinja | |
| JP2016529309A5 (enExample) | ||
| RU2008136876A (ru) | Применение bifidobacterium longum для предупреждения и лечения воспаления | |
| Zhang et al. | Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens | |
| PH12014501254A1 (en) | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof | |
| JP2013139462A5 (enExample) | ||
| WO2012149615A3 (en) | Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme | |
| ME03805B (me) | UPOTREBA KOMPOZICIJE KOlA OBUHVATA MIKROORGANIZME ZA POVEĆANJE INTESTINALNE PROIZVODNJE BUTERNE KISELINE, FOLNE KISELINE ILI NIACINA I/ILI SMANJENJE INTESTINALNE PROIZVODNJE ĆILIBARNE KISELINE | |
| RU2018105964A (ru) | Композиция и способ лечения и профилактики кишечной инфекции и воспаления | |
| RU2015129066A (ru) | Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности | |
| JP2015523321A5 (enExample) | ||
| JP2013147469A5 (enExample) | ||
| Yang et al. | Non-antibiotic therapy for Clostridioides difficile infection: A review | |
| JP2015525566A5 (enExample) | ||
| RU2015122255A (ru) | Хитин или его производные для предотвращения и/или лечения паразитарных заболеваний | |
| PH12016500271A1 (en) | Probiotic for infantile excessive crying |